BIVI: BioVie Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

BioVie Inc.

NASDAQ:BIVI

SummaryFactSheetFinancial
Price
$1.32
Loss Chance
59.1%
n/aJITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Related
Aurinia Pharmaceuticals
NASDAQ:AUPH
5.68
$15.99
36.06%
Aurinia Pharmaceuticals
NASDAQ:AUPH
5.68
$15.99
36.06%
Compugen Ltd.
NASDAQ:CGEN
4.58
$2.83
55.35%
Catalyst Pharmaceuticals
NASDAQ:CPRX
6.36
$31.14
42.91%
Exelixis
NASDAQ:EXEL
6.93
$49.46
33.06%
Jitta Factors
Growth Opportunity (8)
Recent Business Performance (17)
Financial Strength (40)
Return to Shareholders (3)
Competitive Advantage (5)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Cash Conversion CycleLess than 30 days
CapExVery High
Key Stats
Jitta Score
Jitta Line
n/a
100.00%
2.21
147.57%
3.06
203.93%
Biotechnology
5.68
36.06%
5.68
36.06%
4.58
55.35%
COMPANY DESCRIPTION
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer’s disease; and in Phase 2 clinical trial to treat Parkinson’s disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
bioviepharma.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.